Skip to content

VISTAS Itch Trial – Entry Age Now 16 Years


Entry requirements altered

Youngest age to take part is now 16 years

The VISTAS Study is seeking patients diagnosed with PSC to evaluate whether the investigational drug volixibat is a safe and effective treatment option for PSC itch.

Until recently, only adults were allowed to take part. The entry requirements for the study have now been updated to allow 16 year olds with itch to be assessed to participate at selected sites.